Platelet activation and the CD40/CD40 ligand pathway: Mechanisms and implications for human disease

Silvio Danese, Claudio Fiocchi

Research output: Contribution to journalArticle

Abstract

The discovery that platelets express CD40 and the CD40 ligand has transformed these cells, once seen as exclusively involved in coagulation and thrombosis, into active players of immunity and inflammatory injury. Many of the broad and potent biological activities mediated through the CD40/CD40 pathway by immune and nonimmune cells are also exerted by activated platelets. This occurs either through the constitutive expression of CD40 on the platelet surface or the activation-induced expression of the CD40 ligand, which is membrane bound and released from the surface in a soluble form. The most prominent activities mediated by the platelet CD40/ CD40 ligand pathway include inflammatory, immunoregulatory, and hemostatic functions, all of which contribute to the newly expanded view of platelets as key biological mediators involved in disease processes such as atherosclerosis, inflammatory bowel disease, and diabetes. Therefore, considering platelet CD40 and CD40 ligand as novel biological targets is justified and supported by animal studies. The clinical profit to be gained from blocking this molecular pair will be determined by results in humans with conditions in which the platelet CD40/CD40 ligand pathway is crucially involved in disease pathogenesis.

Original languageEnglish
Pages (from-to)103-121
Number of pages19
JournalCritical Reviews in Immunology
Volume25
Issue number2
DOIs
Publication statusPublished - 2005

Fingerprint

CD40 Ligand
Platelet Activation
Blood Platelets
Active Immunity
Hemostatics
Inflammatory Bowel Diseases
Atherosclerosis
Thrombosis
Membranes
Wounds and Injuries

Keywords

  • Atherosclerosis
  • Diabetes
  • Hemostasis
  • Immunoregulation
  • Inflammation
  • Inflammatory bowel disease

ASJC Scopus subject areas

  • Immunology

Cite this

Platelet activation and the CD40/CD40 ligand pathway : Mechanisms and implications for human disease. / Danese, Silvio; Fiocchi, Claudio.

In: Critical Reviews in Immunology, Vol. 25, No. 2, 2005, p. 103-121.

Research output: Contribution to journalArticle

@article{78d3753908a54812a72bb4ef7accb606,
title = "Platelet activation and the CD40/CD40 ligand pathway: Mechanisms and implications for human disease",
abstract = "The discovery that platelets express CD40 and the CD40 ligand has transformed these cells, once seen as exclusively involved in coagulation and thrombosis, into active players of immunity and inflammatory injury. Many of the broad and potent biological activities mediated through the CD40/CD40 pathway by immune and nonimmune cells are also exerted by activated platelets. This occurs either through the constitutive expression of CD40 on the platelet surface or the activation-induced expression of the CD40 ligand, which is membrane bound and released from the surface in a soluble form. The most prominent activities mediated by the platelet CD40/ CD40 ligand pathway include inflammatory, immunoregulatory, and hemostatic functions, all of which contribute to the newly expanded view of platelets as key biological mediators involved in disease processes such as atherosclerosis, inflammatory bowel disease, and diabetes. Therefore, considering platelet CD40 and CD40 ligand as novel biological targets is justified and supported by animal studies. The clinical profit to be gained from blocking this molecular pair will be determined by results in humans with conditions in which the platelet CD40/CD40 ligand pathway is crucially involved in disease pathogenesis.",
keywords = "Atherosclerosis, Diabetes, Hemostasis, Immunoregulation, Inflammation, Inflammatory bowel disease",
author = "Silvio Danese and Claudio Fiocchi",
year = "2005",
doi = "10.1615/CritRevImmunol.v25.i2.20",
language = "English",
volume = "25",
pages = "103--121",
journal = "Critical Reviews in Immunology",
issn = "1040-8401",
publisher = "Begell House Inc.",
number = "2",

}

TY - JOUR

T1 - Platelet activation and the CD40/CD40 ligand pathway

T2 - Mechanisms and implications for human disease

AU - Danese, Silvio

AU - Fiocchi, Claudio

PY - 2005

Y1 - 2005

N2 - The discovery that platelets express CD40 and the CD40 ligand has transformed these cells, once seen as exclusively involved in coagulation and thrombosis, into active players of immunity and inflammatory injury. Many of the broad and potent biological activities mediated through the CD40/CD40 pathway by immune and nonimmune cells are also exerted by activated platelets. This occurs either through the constitutive expression of CD40 on the platelet surface or the activation-induced expression of the CD40 ligand, which is membrane bound and released from the surface in a soluble form. The most prominent activities mediated by the platelet CD40/ CD40 ligand pathway include inflammatory, immunoregulatory, and hemostatic functions, all of which contribute to the newly expanded view of platelets as key biological mediators involved in disease processes such as atherosclerosis, inflammatory bowel disease, and diabetes. Therefore, considering platelet CD40 and CD40 ligand as novel biological targets is justified and supported by animal studies. The clinical profit to be gained from blocking this molecular pair will be determined by results in humans with conditions in which the platelet CD40/CD40 ligand pathway is crucially involved in disease pathogenesis.

AB - The discovery that platelets express CD40 and the CD40 ligand has transformed these cells, once seen as exclusively involved in coagulation and thrombosis, into active players of immunity and inflammatory injury. Many of the broad and potent biological activities mediated through the CD40/CD40 pathway by immune and nonimmune cells are also exerted by activated platelets. This occurs either through the constitutive expression of CD40 on the platelet surface or the activation-induced expression of the CD40 ligand, which is membrane bound and released from the surface in a soluble form. The most prominent activities mediated by the platelet CD40/ CD40 ligand pathway include inflammatory, immunoregulatory, and hemostatic functions, all of which contribute to the newly expanded view of platelets as key biological mediators involved in disease processes such as atherosclerosis, inflammatory bowel disease, and diabetes. Therefore, considering platelet CD40 and CD40 ligand as novel biological targets is justified and supported by animal studies. The clinical profit to be gained from blocking this molecular pair will be determined by results in humans with conditions in which the platelet CD40/CD40 ligand pathway is crucially involved in disease pathogenesis.

KW - Atherosclerosis

KW - Diabetes

KW - Hemostasis

KW - Immunoregulation

KW - Inflammation

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=21344454903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344454903&partnerID=8YFLogxK

U2 - 10.1615/CritRevImmunol.v25.i2.20

DO - 10.1615/CritRevImmunol.v25.i2.20

M3 - Article

C2 - 15952932

AN - SCOPUS:21344454903

VL - 25

SP - 103

EP - 121

JO - Critical Reviews in Immunology

JF - Critical Reviews in Immunology

SN - 1040-8401

IS - 2

ER -